title: Reply to: SNCA variants are associated with increased risk of multiple system atrophy.
authors.forename: Owen A
authors.initials: OA
authors.lastname: Ross
authors.forename: Carles
authors.initials: C
authors.lastname: Vilariño-Güell
authors.forename: Zbigniew K
authors.initials: ZK
authors.lastname: Wszolek
authors.forename: Matthew J
authors.initials: MJ
authors.lastname: Farrer
authors.forename: Dennis W
authors.initials: DW
authors.lastname: Dickson
mesh_terms: D001483:Base Sequence / Q000235:genetics; D001921:Brain / Q000378:metabolism / Q000473:pathology / Q000503:physiopathology; D004252:DNA Mutational Analysis; D005819:Genetic Markers; D020022:Genetic Predisposition to Disease / Q000235:genetics*; D005820:Genetic Testing; D014644:Genetic Variation / Q000235:genetics; D006720:Homozygote; D006801:Humans; D019578:Multiple System Atrophy / Q000235:genetics* / Q000378:metabolism* / Q000503:physiopathology; D016017:Odds Ratio; D020641:Polymorphism, Single Nucleotide / Q000235:genetics*; D012044:Regression Analysis; D015203:Reproducibility of Results; D012307:Risk Factors; D051844:alpha-Synuclein / Q000235:genetics*
chemical_list: D005819:Genetic Markers; C497604:SNCA protein, human; D051844:alpha-Synuclein